The Efficacy Of Adjunctive Garcinia Mangostana Linn. Pericarp For Bipolar Depression: A 24-week Double-blind, Randomized, Placebo-controlled Trial.
Funder
National Health and Medical Research Council
Funding Amount
$1,227,272.00
Summary
Bipolar disorder, especially during episodes of depression, can be highly debilitating. There is scientific evidence now directing research towards new targets to produce new therapies for bipolar depression. The current study aims to utilise an entirely new agent made from the husk of the mangosteen fruit (mangosteen pericarp). Mangosteen pericarp has properties that we believe will assist in reducing symptoms for those with bipolar depression, when taken in addition to usual treatment.
The Efficacy Of Adjunctive S-Adenosyl Methionine (SAMe) Versus A Combination Nutraceutical In Clinical Depression: A Double-Blind, Randomised, Placebo-Controlled Trial
Funder
National Health and Medical Research Council
Funding Amount
$800,264.00
Summary
An emerging approach to treat depression is via the use of adjunctive nutraceuticals (nutrient-based natural products). Specific antidepressant nutraceuticals can target a range of key neurological pathways that can treat depression. We are conducting an 8 week clinical trial comparing the efficacy of a range of nutraceuticals- such as folic acid, omega-3, and zinc, in adults with depression who are non-responsive to current pharmaceutical antidepressants.
Nutraceuticals And Lifestyle Modification For Mood And Anxiety Disorders
Funder
National Health and Medical Research Council
Funding Amount
$425,048.00
Summary
Mood and anxiety disorders cause immense societal impact, and current treatment can be greatly improved. One particular way is via evidence-based use of nutrients and plant-based medicines, in addition to encouraging specific lifestyle changes (e.g. increased physical activity and improved diet). Dr Sarris' research focuses on these areas, aiming to build a robust body of evidence as to which of these interventions work (and which do not) to enhance better treatment of depression and anxiety.
Research & Training To Reduce Morbidity & Mortality From Malaria In Papua ( Indonesia)& Papua New Guinea
Funder
National Health and Medical Research Council
Funding Amount
$1,649,828.00
Summary
Malaria kills many thousands of people each year in Indonesia and PNG. This project will look at better ways to treat and prevent malaria. The team will examine whether using new combinations of drugs in clinics can reduce the amount of severe malaria seen in Papua. The team will examine whether giving people with severe malaria arginine, a naturally occurring amino acid, can increase molecules that may protect against severe malaria. Finally it will examine how lung damage occurs in people with ....Malaria kills many thousands of people each year in Indonesia and PNG. This project will look at better ways to treat and prevent malaria. The team will examine whether using new combinations of drugs in clinics can reduce the amount of severe malaria seen in Papua. The team will examine whether giving people with severe malaria arginine, a naturally occurring amino acid, can increase molecules that may protect against severe malaria. Finally it will examine how lung damage occurs in people with severe malaria and whether this can be predicted.Read moreRead less
IMPROVING PULMONARY TUBERCULOSIS (TB) OUTCOMES: Investigating Novel Adjunctive Immunotherapies And Addressing HIV-TB Co-infection In Papua, Indonesia
Funder
National Health and Medical Research Council
Funding Amount
$217,846.00
Summary
Tuberculosis remains a major regional and global problem, especially in resource-limited settings such as Australia’s northern neighbours. Three key challenges are to make TB cure easier by shortening treatment, improve HIV-TB co-infection management, and tackle drug resistance. We address these issues in Indonesia’s Papua Province, where we are testing whether simple supplements given with TB treatment might accelerate cure; improving HIV care in people with TB, and detecting drug-resistant TB.
Endothelial Dysfunction As A Therapeutic Target In Severe Malaria
Funder
National Health and Medical Research Council
Funding Amount
$842,329.00
Summary
Even with very best drugs to kill malaria parasites, over 15% of patients with severe malaria still die. Their blood vessels are clogged up by malaria parasites. We have shown that the cells lining their blood vessels can't make enough nitric oxide to keep them non-sticky and allow blood through. We want to test whether giving arginine can 1) increase nitric oxide, 2) open up the clogged blood vessels and 3) dampen down other processes that clog up blood vessels in severe malaria.
Optimizing The Management Of Osteoarthritis Through Research And Innovation
Funder
National Health and Medical Research Council
Funding Amount
$2,889,164.00
Summary
I will test new treatments aimed at slowing disease progression and reducing pain in osteoarthritis (OA) by targeting specific disease pathways (metabolic factors and inflammation). I will undertake work examining the causes of hip OA where little is known. All required methodologies and resources to undertake this work are available and the trials underpinned by strong scientific rationale. This research program has high potential for translation and for reducing the burden and cost of OA.
The Biology Of Cervical Disc Damage And Stem Cell Applications For Repair.
Funder
National Health and Medical Research Council
Funding Amount
$82,554.00
Summary
Disruption of the cervical disc by degeneration or trauma is common and therefore a major public health issue causing significant pain and disability in the community. The understanding of the changes that occur in disc degeneration would be greatly enhanced by comparison with changes that occur in normal discs and in discs recently disrupted by trauma. Potential applications of adult stem cells or their derivatives for disc repair and regeneration will be explored.